• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of inquiries resolved via IAS Action within 10 business days of date assigned during the month

Dictionary: Globalization changed FDA’s environment for regulating products. Based on the volume of imported products, FDA identified China, India, the Middle East, Europe, and Latin America as areas in which to establish a permanent presence. These foreign posts send inquiries/requests for information to FDA headquarters. The International Affairs Staff in the Office of the Center Director is responsible for responding and/or coordinating responses with technical experts to inquiries from foreign posts concerning food and cosmetic products. This measure evaluates CFSAN's timeliness in responding to these inquiries.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercentage
Oct 20108596
Nov 201085100
Dec 20108595
Jan 201185100
Feb 201185100
Mar 201185100
Apr 20118588
May 20118591
Jun 20118588
Jul 20118592
Aug 20118597
Sep 20118598

FY 2011 Overall: 96%

Number of inquiries resolved via IAS Action within 10 business days of date assigned during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A24
Nov 2010N/A20
Dec 2010N/A42
Jan 2011N/A21
Feb 2011N/A13
Mar 2011N/A22
Apr 2011N/A21
May 2011N/A21
Jun 2011N/A7
Jul 2011N/A35
Aug 2011N/A28
Sep 2011N/A47

FY 2011 Total: 301

Total number of inquiries received via IAS Action during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A25
Nov 2010N/A20
Dec 2010N/A44
Jan 2011N/A21
Feb 2011N/A13
Mar 2011N/A22
Apr 2011N/A24
May 2011N/A23
Jun 2011N/A8
Jul 2011N/A38
Aug 2011N/A29
Sep 2011N/A48

FY 2011 Total: 315

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.